Alexander Snyder 2021. For Profit or For Health? It is Time to Reckon With the Current Pharmaceutical Landscape Through a Systematic Analysis of Monoclonal Anitbodies. Pittsburgh Journal of Technology Law & Policy. 21, 2 (Aug. 2021). DOI:https://doi.org/10.5195/tlp.2021.251.